Global Pricing & Market Access Director, Oncology Diagnostics
- Experience Level
- Experienced (non-manager)
Location: Cambridge, UK or Gaithersburg, USA
Salary: Competitive with excellent benefits
AstraZeneca is committed to ensuring that its oncology medicines reach the right patients at the right time and see precision medicine as a key enabler of this. Many of our current brands and the majority of our pipeline have our therapy's treatment guided by some form of diagnostic approach. Ensuring the relevant diagnostic technologies are funded and available at the time treatment decisions are made (whether in the moment or via historical biopsy) is critical to safeguard that the patient benefits of our therapies are realised in the real world, delivering maximum value to patients, healthcare professionals and patients. The pricing, reimbursement and access for companion or complementary diagnostics usually does not follow the same payer assessment process as pharmaceuticals in most countries. In addition, the majority of test that enable guided therapy with AZ medicines are developed and manufactured by external stakeholders such as diagnostics companies or laboratories.
AstraZeneca is making a strategic investment in a Global Diagnostics capability within the Oncology Business Unit focusing on marketing and market access, external partnerships and scientific affairs, with the aim that we have the right approach to achieve access and awareness of relevant diagnostic test, collaborate effectively with external partners, and follow the science on new ways of identifying patients who can benefit most.
The Global Pricing and Market Access Director (PMAD), Diagnostics will be a key part of this strategic capability uplift. Reporting into Oncology Market Access and Pricing, the individual will collaborate with franchise PMADs and the Global Diagnostics team to define the diagnostics strategies needed to ensure that patients receive access to our therapies by delivering access to the appropriate diagnostic methodology. Key stakeholders will include the Global Diagnostics Leadership team, Global Product Teams and external stakeholders that manufacture diagnostics. This is a brand new role, dedicating to supporting the overall diagnostics capability uplift for AZ, and the role holder will be required to be self-starting, a subject matter expert in diagnostics and be able to lead cross functional teams to achieve a new way of working in AZ.
Develop Global strategy to secure Market Access and Reimbursement for biomarkers as enablers for AZ targeted therapies in conjunction with diagnostic partners
Lead cross functional Global Dx workstream comprising of: Pricing & Market Access Directors; Global Diagnostic Directors; Global Oncology Policy Director; Global Commercial Director and other GPT members.
Whilst a member of OMAP, will have a dotted line and sit on the Global Diagnostics LT and Global Corporate Policy LT.
Predict future diagnostic reimbursement trends through horizon scanning and develop above brand and franchise specific strategies to anticipate these developments.
Partner with Governmental Affairs facilitate policy shaping for precision medicine concept and solutions.
Build relations with and influence external stakeholders including Payers, Diagnostics KEEs, and other HCPs to gain strategic insights and through those develop and implement value propositions for Diagnostics solutions.
Monitor diagnostics competitive environment to anticipate risks and opportunities that can impact reimbursement and access for our franchises.
Align and integrate Diagnostics Market Access strategic plans into priority Brand Strategy Plans in order to achieve overall commercial strategic objective.
Understand, describe and prioritize most relevant (influential, accessible) market access stakeholders (payers, governmental bodies, industry associations, professional associations and other stakeholders) in order to facilitate policy shaping for personalized medicine
Develop external communication platforms for marketing company diagnostic teams to leverage, in order to reinforce the value messages for our products (e.s. workshops, payer info material).
Build local marketing company capabilities in negotiation so that our diagnostics are embedded in the reimbursement processes Globally. Build capabilities around the strategy, funding and tactical pull through needs for diagnostics
Establish new innovative value strategies (IVS) and contractual schemes for pharmacodiagnostics.
Collaborate with diagnostic partner to facilitate establishment of new reimbursement procedural, product codes and pathways for diagnostic products
Collaborate with diagnostic partner to develop and aligned strategy for achieving reimbursement of the diagnostic along side AZ' therapy. Ensure successful execution.
B.A. or B.S. Degree in Medicine, Economics or Science.
Preferred Master's Degree in Medicine, Business Administration, Public Health, Health Economics or Health Policy.
Seasoned in Diagnostics, Pricing, Access, and Reimbursement
Successful track record in leading cross functional teams at Global, Regional and Local levels
Negotiation skills and ability to make sound business arguments to influence external decision makers
Proven success in evidence-based medicine and/or public health and/or market access and/or competitive effectiveness research and/or health economics
Strategic understanding of the business and strategic thinking
Existing network to local market access stakeholders
Ability to operate effectively in changing environment, create business plane to anticipate and address changes